DOC vs MAC
Healthpeak Properties vs The Macerich Company — AI-powered side-by-side comparison
DOC
Healthpeak Properties
64
Buy
VS
MAC
The Macerich Company
60
Insufficient Data
| Metric | DOC | MAC |
| AI Score |
64
|
60
|
| Price |
$20.50
|
$24.57
|
| P/E Ratio |
58.60×
|
-37.74×
|
| ROE |
1.0%
|
-8.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
2.5%
|
24.5%
|
| Debt / Equity |
1.32×
|
1.71×
|
| Dividend Yield |
5.9%
|
2.8%
|
| RSI (14) |
31.1
|
42.2
|
| Beta |
0.991
|
2.073
|
| Expected Upside |
+1.6%
|
—
|
AI Committee View
Current Innellis committee reasoning for DOC versus MAC.
DOC leads by 4 points.
DOC scores 64/100 (Buy) versus MAC at 60/100 (Insufficient Data).
DOC Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Price trading below the lower Bollinger Band -- stretched to the downside — Technical
MAC Committee View
67% agreement
3 analysts
Some positive signals exist — vix regime is low -- calm backdrop supports risk-taking — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical